Dae-im Jung

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model.

An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model.

Journal: Virus research
Published: July 06, 2026

Correction: Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice.

Correction: Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice.

Journal: Virology journal
Published: June 05, 2026

A PRNT-anchored OD-based micro-neutralization cytopathic effect assay for rapid screening of adenovirus neutralizing activity.

A PRNT-anchored OD-based micro-neutralization cytopathic effect assay for rapid screening of adenovirus neutralizing activity.

Journal: Diagnostic microbiology and infectious disease
Published: May 04, 2026

Development and analytical evaluation of a microneutralization cytopathic effect assay for human adenovirus type 55-specific neutralizing antibodies.

Development and analytical evaluation of a microneutralization cytopathic effect assay for human adenovirus type 55-specific neutralizing antibodies.

Journal: Journal of microbiology (Seoul, Korea)
Published: April 06, 2026

Establishment of a Cynomolgus Macaque Model for Human Adenovirus Type 55-Induced Respiratory Disease.

Establishment of a Cynomolgus Macaque Model for Human Adenovirus Type 55-Induced Respiratory Disease.

Journal: The Journal of infectious diseases
Published: May 15, 2025

Mouse strain-dependent neutralizing antibody responses to Zika virus vaccines.

Mouse strain-dependent neutralizing antibody responses to Zika virus vaccines.

Journal: Journal of microbiology (Seoul, Korea)
Published: April 04, 2025

Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice.

Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice.

Journal: Virology journal
Published: August 07, 2024

Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV.

Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV.

Journal: Scientific reports
Published: December 28, 2022

Induction of protective immune responses against a lethal Zika virus challenge post-vaccination with a dual serotype of recombinant vesicular stomatitis virus carrying the genetically modified Zika virus E protein gene.

Induction of protective immune responses against a lethal Zika virus challenge post-vaccination with a dual serotype of recombinant vesicular stomatitis virus carrying the genetically modified Zika virus E protein gene.

Journal: The Journal of general virology
Published: April 29, 2021

Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.

Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.

Journal: Journal of virology
Published: June 15, 2020

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.

Journal: Virus research
Published: October 18, 2019

Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection.

Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection.

Journal: Frontiers in immunology
Published: September 17, 2018
Showing 1-12 of 13

Last Updated: 09/26/2026